RayStation and RayCare on show at ESTRO 36

During 6–8 May, RaySearch will be exhibiting at the ESTRO 36 congress in Vienna, Austria. The company will demonstrate the innovative features in the latest release of its treatment planning system, RayStation®. In addition, RaySearch will give preview demonstrations of its forthcoming oncology information system, RayCare®*, which is due to be launched in the second half of 2017. Attendees are welcome to visit RaySearch at booth #1600, and demonstrations can be booked now at www.raysearchlabs.com .

New features in RayStation 6
New functionality and a wide range of general improvements will all be on show. Major additions include support for the Accuray Radixact™ System*. RayStation will be the only system that enables planning for both conventional linacs and the Accuray TomoTherapy platform treatment delivery system, giving one point of control for all treatment planning activities. Björn Hårdemark, Deputy CEO of RaySearch, will present a preview of the system in the Accuray booth on Sunday, 7 May 1 from 16:05 to 16:25. Demonstrations can also be booked by visiting the RaySearch and Accuray booths.

RayStation 6 also introduces simultaneous optimization of multiple beam sets for SMLC, DMLC and VMAT, and MR-based planning, which makes it possible to use an MR image as the planning image for photon therapy. Other highlights on show include Monte Carlo dose calculation for proton pencil beam scanning (PBS) and PBS planning with block apertures.

Automated planning and Plan Explorer
RayStation has extensive automated planning features that help optimize workflows and create new treatment possibilities. Plan Explorer, for example, makes it possible to automatically generate a large number of high-quality treatment plan alternatives, saving valuable time and giving the clinician a wide range of options to consider.

Adaptive therapy
RayStation is designed to make adaptive therapy easy to implement and perform in clinical practice. At the RaySearch booth, attendees can discover how automation features and smart tools in the fully integrated dose tracking and adaptive planning modules make it straightforward to get started.

The next-generation OIS
RayCare has been developed from the ground up by RaySearch to support the complex logistical challenges in modern, large-scale radiation therapy centers. RayCare integrates the high-performance radiation therapy algorithms available in RayStation and adds advanced features for clinical resource optimization, workflow automation and adaptive radiation therapy.

Lunch symposium: Advancing cancer treatment through software innovation
On Saturday 6 May from 13.15–14.15, Room LEHAR 1–3, RaySearch will hold a lunch symposium focused on how software is driving innovation in oncology.

Moderator: Simeon Nill, Head of Translational Radiotherapy Physics, Joint Department of Physics at The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, London, UK.

Advancing cancer treatment through software innovation
Johan Löf, Founder & CEO, RaySearch Laboratories AB, Stockholm, Sweden

How to contribute to evidence-based radiotherapy in routine daily practice. From dream to reality.
Johannes A. Langendijk, Professor and Chair of the Department of Radiation Oncology, University Medical Centre Groningen, Groningen, Netherlands

Using RayStation as a unified treatment planning system to free up physicians’ time
Xavier Mirabel, Professor and Chair of the Department of Radiation Therapy, Centre Oscar Lambret, Lille, France

About RayStation
RayStation integrates all RaySearch’s advanced treatment planning solutions into a flexible treatment planning system. It combines unique features such as multi-criteria optimization tools with full support for 4D adaptive radiation therapy. It also includes functionality such as RaySearch’s market-leading algorithms for IMRT and VMAT optimization and highly accurate dose engines for photon, electron, proton and carbon ion therapy. The system is built on the latest software architecture and features a graphical user interface with state-of-the-art usability.

About RayCare
RayCare is a next generation OIS developed from the ground up by RaySearch to support the complex logistical challenges in modern, large-scale radiation therapy centers. RayCare integrates the high performance radiation therapy algorithms available in RayStation and adds advanced features for clinical resource optimization, workflow automation and adaptive radiation therapy.

About RaySearch
RaySearch Laboratories AB (publ) is a medical technology company that develops innovative software solutions for improved cancer treatment. RaySearch markets the RayStation treatment planning system to clinics all over the world and distributes products through licensing agreements with leading medical technology companies. The company is also developing the next-generation oncology information system, RayCare, which comprises a new product area for RaySearch, and which will be launched in 2017. RaySearch’s software is used by over 2,600 clinics in more than 65 countries. The company was founded in 2000 as a spin-off from Karolinska Institutet in Stockholm and the share has been listed on NASDAQ Stockholm since November 2003.

More information about RaySearch is available at www.raysearchlabs.com

* Subject to regulatory clearance in some markets.

  For further information, please contact:
Johan Löf, President and CEO, RaySearch Laboratories AB (publ)
Telephone: +46 (0)8-510 530 00
johan.lof@raysearchlabs.com

About Us

RaySearch Laboratories is a medical technology company that develops advanced software solutions for improved radiation therapy of cancer. RaySearch markets the RayStation® treatment planning system to clinics all over the world. In addition, RaySearch’s products are distributed through licensing agreements with leading medical technology companies such as Philips, Nucletron, IBA, Varian and Brainlab. To date, 15 products have been launched via partners and RaySearch’s software is used by over 2,500 clinics in more than 65 countries. RaySearch was founded in 2000 as a spin-off from Karolinska Institute in Stockholm and the company is listed in the Small Cap segment on Nasdaq Stockholm.

Subscribe

Media

Media

Documents & Links